Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Peter Richard Roth has worked on the following 3 EPO patent applications which have been published in the last five years:

EP12177119

Crystal form H of imatinib mesylate

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/04, C07D 401/14
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12177131

G, I and K crystal forms of imatinib mesylate

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/04
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13718720

METHOD OF TREATING GASTROINTESTINAL STROMAL TUMORS

IPC classification:
A61K 31/4709, A61K 31/506, A61P 35/00
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature